Tumor necrosis factor (TNF) inhibitors for the treatment of psoriatic arthritis

This is a protocol for a Cochrane Review (intervention). The objectives are as follows:

To assess the benefits and harms of TNF inhibitors in comparison with placebo and other treatment strategies in adult patients affected by psoriatic arthritis.

This is a protocol.

Health topics:

Rheumatology > Spondylo-arthropathy

Share

Published:

14 May 2020

Authors:

Cagnotto G, Compagno M, Scire CAlberto, Bruschettini M

Primary Review Group:

Musculoskeletal Group

See the full Review on

the Cochrane Library

Print
PDF
Citation
Cagnotto G, Compagno M, Scire CAlberto, Bruschettini M. Tumor necrosis factor (TNF) inhibitors for the treatment of psoriatic arthritis (Protocol). Cochrane Database of Systematic Reviews 2020, Issue 5. Art. No.: CD013614. DOI: 10.1002/14651858.CD013614.